—MGM
— • —
$37.32
P/E
52.74
PEG
—
FCF Yield
—
Rev Growth YoY
+172.0% YoY
Gross Margin
4442.0%
Health Score
4/10
D/E Ratio
2.67
Confidence
LOW
Business Snapshot
The ticker and exchange data for this security are not fully identified in the payload, which limits contextual framing. Based on available financial ratios — a Price/Sales of 0.54x and an EV/EBITDA of 9.56x — this appears to be a capital-intensive business generating meaningful revenue relative to its market price. The current price sits at $37.32, and without a market capitalisation figure, cap-tier classification cannot be confirmed.
Financial Health
**Score: 4/10** The company presents a deeply contradictory financial picture. On the surface, a reported gross margin of 4,442% and a net margin of 117% appear extraordinary — but these figures are statistical outliers that likely reflect one-time accounting items, asset sales, or a very small revenue base, and should be treated with extreme caution rather than as indicators of ongoing operational health...
Risk Assessment
- **DEBT:** Debt/equity of 2.67x indicates the company is highly leveraged, creating vulnerability to interest rate changes and refinancing risk. - **EARNINGS DETERIORATION:** Earnings growth of -7,053% year-over-year represents a near-total collapse in profitability despite strong revenue expansion. - **VALUATION PREMIUM:** P/E of 52.74x is more than double the sector average of ~25x, leaving limited margin of safety if growth disappoints. - **DATA GAPS:** Free cash flow, TTM revenue, TTM net income, market cap, and DCF fair value are all unavailable, making comprehensive fundamental analysis impossible. - **TECHNICALS:** A confirmed death cross (50-day MA crossing below 200-day MA) and bearish MACD signal indicate deteriorating price momentum. ---...